J Funct 2020
In terms of direct cardiovascular observations from trial data, retatrutide has been associated with modest, dose-dependent increases in resting heart rate , a finding also observed with other GLP-1 receptor agonists (as reflected in the Summary of Product Characteristics for semaglutide and tirzepatide)
L.CohenJ
candidate who studies how the gut and nervous system negotiate pain, I keep returning to a question I havent seen asked loudly enough: What happens to a body that already makes GLP-1 naturally when we flood it with pharmacological doses of the same signal
For each sleep outcome, we systematically tested the model by first examining the main effect of bedtime kratom use without interaction terms (Model 1), then adding the sex interaction term (Model 2), and finally testing the chronic pain status interaction term (Model 3)
It has three domains: a mutated GLP-1 (A8G) fragment with enhanced DPP-4 resistance, a humanized human serum albumin (HSA) nanobody that binds HSA to extend half-life by preventing rapid clearance, and a humanized GLP-1R nanobody that activates the GLP-1R signaling pathway upon dissociation from HSA
